A Study to Assess the Effects of BPN14770 on Rosuvastatin
A Phase 1, Open-label, 1-Sequence Crossover, Drug-drug Interaction Study to Assess the Effect of Repeated Doses of BPN14770 on the Pharmacokinetics of Rosuvastatin in Healthy Adult Participants
Sponsor: Shionogi
Listed as NCT07011992, this PHASE1 trial focuses on Healthy Participants and remains completed. Sponsored by Shionogi, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
Status: Not Yet Recruiting → Completed
-
Jul 2025 — Sep 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Shionogi
For direct contact, visit the study record on ClinicalTrials.gov .